Orbit Chain faces crypto theft of about $100 million
时间:2024-06-26 13:01:16 阅读(143)
With insights from blockchain security firms, attack on Orbit Chain’s cross-chain bridge has pushed up the amount of crypto stolen in December 2023 to almost $100 million, stated Cointelegraph.
“PeckShieldAlert Hackers stole $99.3 million across over 36 attacks in December.The Cross-chain #OrbitBridge suffered an $81.5 million exploit on New Year’s Eve, marking it as the 9th top hack targeting a cross-chain bridge in the last 3 years,” PeckShieldAlert tweeted.
“We are in close contact with law enforcement agencies, and we are working diligently to track down and freeze the assets that have been stolen,” Orbit Chain concluded.
(With insights from Cointelegraph)
Follow us on Twitter, Facebook, LinkedIn
猜你喜欢
- Bosch, Cummins India, Blue Star among 40 NSE stocks to hit 52-week highs; 38 touch 52-week lows
- Petrol and Diesel Rate Today, 22 December- Fuel rates steady; Check prices in Delhi, Mumbai, other cities
- Petrol and Diesel Rate Today, 24 March- Fuel prices unchanged; Check rates in Delhi, Mumbai, other cities
- Today, 21 Sep 2022- Fuel cost steady; check rates in Delhi, Mumbai, Noida, other cities
- Petrol and Diesel Rate Today, 25 Nov- Rates remain steady
- Bharatmala project to be subsumed in Vision 2047
- Bulls to stage a comeback or bears to drag Nifty below 16750- 5 things to know before market opening bell
- s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
- Bull case for Nifty at 20,919 in 2023- Kotak Securities